Silence Therapeutics plc (SLN)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Quarterly

0 9M 18M 27M Q3 '24: 1.5M Q4 '24: 25.3M Q1 '25: 142K Q2 '25: 224K Q3 '25: 159K Q4 '25: 34K Q1 '26: 422K Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Gross Profit Quarterly

-8M 0 8M 16M 24M Q3 '24: -2.1M Q4 '24: 23.3M Q1 '25: 88K Q2 '25: 139K Q3 '25: 95K Q4 '25: 22K Q1 '26: 411K Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Income Quarterly

-30M -15M 0 15M 30M 45M Q3 '24: -30M Q4 '24: -4.4M Q1 '25: -28.4M Q2 '25: -24M Q3 '25: -26.2M Q4 '25: -12.5M Q1 '26: -15.7M Q2 '26: -13.9M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Net Income Quarterly

-45M -30M -15M 0 15M 30M 45M Q3 '24: -35.5M Q4 '24: 12.3M Q1 '25: -28.5M Q2 '25: -27.4M Q3 '25: -21M Q4 '25: -11.8M Q1 '26: -15M Q2 '26: -12.3M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Cost of Revenue Quarterly

0 1.5M 3M 4.5M Q3 '24: 3.6M Q4 '24: 2M Q1 '25: 54K Q2 '25: 85K Q3 '25: 64K Q4 '25: 12K Q1 '26: 11K Q2 '26: 0 Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating Cash Flow Quarterly

-30M -20M -10M 0 10M 20M 30M Q3 '24: -25.6M Q4 '24: -27.5M Q1 '25: -12.3M Q2 '25: -21.8M Q3 '25: -10.9M Q4 '25: -17.3M Q1 '26: -15.6M Q2 '26: 1.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Free Cash Flow Quarterly

-30M -20M -10M 0 10M 20M 30M Q3 '24: -25.7M Q4 '24: -27.5M Q1 '25: -12.3M Q2 '25: -21.8M Q3 '25: -10.9M Q4 '25: -17.3M Q1 '26: -15.6M Q2 '26: 1.5M Q3 '24 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

Operating cash flow minus capital expenditure.

Shares Outstanding Quarterly

0 50M 100M 150M Q1 '24: 131.9M Q2 '24: 140.2M Q3 '24: 141.2M Q1 '25: 141.7M Q2 '25: 141.7M Q3 '25: 141.7M Q1 '26: 141.7M Q2 '26: 141.7M Q1 '24 Q2 '24 Q3 '24 Q1 '25 Q2 '25 Q3 '25 Q1 '26 Q2 '26

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-0.75 -0.50 -0.25 0.00 0.25 0.50 0.75 Q4 '24: -0.33 Q1 '25: -0.51 Q2 '25: -0.56 Q3 '25: -0.46 Q4 '25: -0.63 Q1 '26: -0.54 Q2 '26: -0.44 Q4 '24 Q1 '25 Q2 '25 Q3 '25 Q4 '25 Q1 '26 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.